NCT05382559 2026-03-02A Study of ASP3082 in Adults With Advanced Solid TumorsAstellas Pharma IncPhase 1 Recruiting681 enrolled
NCT03504397 2026-02-13SpotlightAstellas Pharma IncPhase 3 Active not recruiting565 enrolled 63 charts 1 FDA
NCT07277270 2026-01-07A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Recruiting84 enrolled